- £1.29bn
- £3.04bn
- £3.01bn
- 47
- 43
- 16
- 24
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,795 | 1,433 | 834 | 2,185 | 3,010 |
Cost of Revenue | |||||
Gross Profit | 1,988 | 1,002 | 599 | 1,575 | 2,173 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,575 | 1,800 | 1,173 | 2,083 | 2,842 |
Operating Profit | 219 | -367 | -338 | 102 | 168 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 197 | -426 | -411 | 25.2 | 88.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 154 | -398 | -362 | 9.9 | 56.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 127 | -375 | -357 | -10.2 | 8.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 127 | -375 | -357 | -10.2 | 8.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.232 | -0.549 | -0.513 | -0.142 | 0.046 |
Dividends per Share | |||||
Special Dividends per Share |